Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Nappi

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Drug Intelligence & Clinical Pharmacy|April 1, 1988
Is there significance beyond the t-testE G Boyce, J M Nappi
Pharmacotherapy|July 1, 1985
Flecainide: a new prototype antiarrhythmic agentJ M Nappi, J L Anderson
Drug Intelligence & Clinical Pharmacy|October 1, 1988
Clinical pharmacy and clinical researchJ M Nappi, J A Bosso
American Journal of Hospital Pharmacy|September 1, 1981
Nafcillin interference with quantitative protein urinalysisJ Felice-Johnson, J M Nappi
Pharmacotherapy|March 20, 2001
Clinical use of new antithrombotic therapies for medical management of acute coronary syndromesB S Wiggins, A K Wittkowsky, J M Nappi
The American Journal of Cardiology|February 1, 1984
Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance studyJ L Anderson, J R Lutz, J M Nappi
The Annals of Pharmacotherapy|April 1, 1996
Possible pharmacokinetic interaction with quinidine: ciprofloxacin or metronidazole?C E Cooke, G E Sklar, J M Nappi
Cardiovascular Drugs and Therapy|August 1, 1990
Antihypertensive monotherapy with tablet (prompt-release) diltiazem: multicenter controlled trialsP E Pool, J M Nappi, M A Weber
The Western Journal of Medicine|January 1, 1983
Severe hypoglycemia associated with disopyramideJ M Nappi, S Dhanani, J R Lovejoy, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Initial and long-term outpatient experience with pirmenol for control of ventricular arrhythmiasE M Hampton, J L Anderson, J R Lutz, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Drug Intelligence & Clinical Pharmacy|April 1, 1988
Is there significance beyond the t-testE G Boyce, J M Nappi
Pharmacotherapy|July 1, 1985
Flecainide: a new prototype antiarrhythmic agentJ M Nappi, J L Anderson
Drug Intelligence & Clinical Pharmacy|October 1, 1988
Clinical pharmacy and clinical researchJ M Nappi, J A Bosso
American Journal of Hospital Pharmacy|September 1, 1981
Nafcillin interference with quantitative protein urinalysisJ Felice-Johnson, J M Nappi
Pharmacotherapy|March 20, 2001
Clinical use of new antithrombotic therapies for medical management of acute coronary syndromesB S Wiggins, A K Wittkowsky, J M Nappi
The American Journal of Cardiology|February 1, 1984
Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance studyJ L Anderson, J R Lutz, J M Nappi
The Annals of Pharmacotherapy|April 1, 1996
Possible pharmacokinetic interaction with quinidine: ciprofloxacin or metronidazole?C E Cooke, G E Sklar, J M Nappi
Cardiovascular Drugs and Therapy|August 1, 1990
Antihypertensive monotherapy with tablet (prompt-release) diltiazem: multicenter controlled trialsP E Pool, J M Nappi, M A Weber
The Western Journal of Medicine|January 1, 1983
Severe hypoglycemia associated with disopyramideJ M Nappi, S Dhanani, J R Lovejoy, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Initial and long-term outpatient experience with pirmenol for control of ventricular arrhythmiasE M Hampton, J L Anderson, J R Lutz, et al.
Pageof 3